ID 404863803 · FY 2018–2024 · 7 years
--- კომპანიის ძირითად საქმიანობას წარმოადგენს რეალიზაცია სამედიცინო მასალები ვაჭრობა.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 38.4% | 40.3% | 42.1% | 42.7% | 38.7% | 41.7% | 36.2% |
| EBITDA Margin | 21.6% | 30.0% | 25.0% | 23.6% | 13.5% | 3.9% | -0.4% |
| EBITDAR | 1,166 | 1,724 | 2,115 | 2,254 | 1,249 | 323 | 86 |
| EBITDAR Margin | 22.9% | 31.5% | 25.7% | 24.7% | 14.8% | 5.8% | 1.6% |
| EBIT Margin | 19.6% | 28.0% | 23.5% | 22.2% | 12.0% | 1.6% | -2.8% |
| Net Profit Margin | 12.3% | 18.1% | 14.2% | 21.4% | 13.9% | 3.0% | -4.6% |
| Operating Expense % of Sales | 16.8% | 10.3% | 17.2% | 19.2% | 25.2% | 37.8% | 36.6% |
| Returns | |||||||
| Return on Assets (ROA) | 6.3% | 9.7% | 10.3% | 16.1% | 10.2% | 1.4% | -1.8% |
| Return on Equity (ROE) | 11.2% | 15.7% | 15.4% | 20.5% | 11.5% | 1.6% | -2.5% |
| ROIC [EBIT / Invested Capital] | 11.3% | 16.3% | 18.5% | 19.2% | 9.2% | 0.8% | -1.2% |
| Leverage & liquidity | |||||||
| Debt-to-Assets | 34.1% | 31.6% | 29.2% | 18.2% | 10.8% | 5.4% | 21.0% |
| Debt-to-Equity | 0.61x | 0.51x | 0.44x | 0.23x | 0.12x | 0.06x | 0.29x |
| Debt-to-EBITDA | 3.11x | 1.96x | 1.61x | 1.03x | 1.08x | 3.00x | N/A |
| Equity-to-Assets | 55.9% | 62.1% | 66.8% | 78.7% | 89.2% | 86.3% | 72.5% |
| Net Debt | 3,224 | 3,076 | 2,899 | 1,005 | 888 | 605 | 2,675 |
| Cash & Equivalents | 184 | 148 | 412 | 1,203 | 349 | 47 | 262 |
| Total Debt | 3,409 | 3,223 | 3,311 | 2,208 | 1,237 | 652 | 2,937 |
| Efficiency & working capital | |||||||
| Inventory Turnover | N/A | 1.71x | 1.91x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | 213.0 | 190.7 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 0.95x | 2.10x | 2.34x | 2.46x | 2.21x | 1.07x | 1.12x |
| Days Sales Outstanding (DSO) | 385.5 | 173.7 | 156.1 | 148.3 | 164.9 | 340.9 | 324.8 |
| Payables Turnover | 3.18x | 5.11x | 11.19x | 14.05x | N/A | 3.23x | 3.82x |
| Days Payable Outstanding (DPO) | 114.8 | 71.5 | 32.6 | 26.0 | N/A | 112.9 | 95.6 |
| Cash Conversion Cycle | 270.6 days | 315.2 days | 314.2 days | 122.3 days | 164.9 days | 228.1 days | 229.2 days |
| Asset Turnover | 0.51x | 0.54x | 0.73x | 0.75x | 0.74x | 0.46x | 0.39x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
Ownership & directors from companyinfo.ge (public corporate registry).